Sign up
Login
Friday 6th November 2015
Multiple Myeloma
13:45 Welcome and Introduction (D. Betticher, Fribourg/M. Ghielmini, Bellinzona)
14:00 Laboratory tests and new diagnostic criteria in MM (L. Bernasconi, Aarau)
14:30 Is there a best triplet for first line treatment? (U. Hess, St Gallen)
15:00 Consolidation and/or maintenance after HDCT (H. Goldschmidt, Heidelberg)
15:30 Discussion of 3 challenging clinical cases (complications of myeloma)
16:00 Coffee break
16:30 Treatment algorithm(s) for non-transplantable patients (C. Taverna, Münsterlingen)
17:00 New drugs for relapsed/refractory MM (C. Driessen, St Gallen)
17:30 Amyloidosis (B. Gerber, Zürich)
18:00 Discussion of 3 challenging clinical cases (management of relapses)
18:30 Adjourn
Saturday 7th November 2015
CLL
08:00 Differential diagnosis of monoclonal lymphocytosis (A. Tichelli, Basel)
08:30 Which is the best anti-CD20 for CLL? (M. Gregor, Luzern)
09:00 Fludarabine, bendamustine or chlorambucil? (C.M. Wendtner, München)
09:30 Discussion of 3 challenging clinical cases (complications of CLL)
10:00 Coffee break
10:30 Allogeneic transplantation: when and how (D. Heim, Basel)
11:00 New drugs for CLL (P. Ghia, Milano)
11:30 Richter’s transformation (D. Rossi, Novara)
12:00 Discussion of 3 challenging clinical cases (management of relapses)
12:30 End